| Literature DB >> 16225702 |
Nonglak Yoonim1, Colleen Olive, Chulabhorn Pruksachatkunakorn, Michael F Good, Sumalee Pruksakorn.
Abstract
BACKGROUND: Group A streptococcal (GAS) infections can lead to the development of severe post-infectious sequelae, such as rheumatic fever (RF) and rheumatic heart disease (RHD). RF and RHD are a major health concern in developing countries, and in indigenous populations of developed nations. The majority of GAS isolates are M protein-nontypeable (MNT) by standard serotyping. However, GAS typing is a necessary tool in the epidemiologically analysis of GAS and provides useful information for vaccine development. Although DNA sequencing is the most conclusive method for M protein typing, this is not a feasible approach especially in developing countries. To overcome this problem, we have developed a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP)-based assay for molecular typing the M protein gene (emm) of GAS.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16225702 PMCID: PMC1274321 DOI: 10.1186/1471-2180-5-63
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Figure 2Agarose gel electrophoresis of emm gene amplicon PCR products (A), and polyacrylamide gel electrophoresis RFLP patterns using Alu I restriction enzyme (B). The size differences of PCR products and RFLP patterns of M1, M11, M49, M12, M25, M48, M112, st11014, M44/61, M93, M81, M104 and M66 are shown in lanes 1–13, respectively. Lane M represents a 100 bp ladder.
PCR products and Alu I restriction fragment sizes and distribution in the Thai GAS isolates studied.
| M type | Size of PCR product (bp) | Size of restriction fragment (bp) | No. (%) of isolates from PCR-RFLP analysis | M type | Size of PCR product (bp) | Size of restriction fragment (bp) | No. (%) of isolates from PCR-RFLP analysis |
| M1 | 1071 | 354 | 16 (15.09%) | M49 | 450 | 336 | 2 (1.89%) |
| 892 | 257 | 252 | |||||
| 744 | 218 | 196 | |||||
| 592 | 147 | 135 | |||||
| 110 | 89 | ||||||
| 87 | 545 | 370 | 1 (0.94%) | ||||
| 47 | 185 | ||||||
| 37 | M66 | 566 | 252 | 1 (0.94%) | |||
| 29 | 450 | 206 | |||||
| M4 | 747 | 314 | 2 (1.89%) | 148 | |||
| 609 | 174 | 123 | |||||
| 476 | 57 | M81 | 649 | 322 | 7 (6.60%) | ||
| 47 | 493 | 185 | |||||
| M11 | 710 | 593 | 8 (7.55%) | 375 | 127 | ||
| 592 | 434 | 84 | |||||
| 450 | 147 | 62 | |||||
| 117 | M89 | 404 | 350 | 1 (0.94%) | |||
| M12 | 1121 | 349 | 3 (2.83%) | 77 | |||
| 116 | M93 | 679 | 254 | 22 (20.75%) | |||
| 93 | 540 | 227 | |||||
| 78 | 411 | 168 | |||||
| 59 | 130 | ||||||
| 51 | 93 | ||||||
| M25 | 649 | 247 | 10 (9.43%) | 53 | |||
| 540 | 203 | M102 | 420 | 332 | 1 (0.94%) | ||
| 148 | 92 | ||||||
| 51 | M104 | 450 | 210 | 3 (2.83%) | |||
| 37 | 146 | ||||||
| M33 | 812 | 347 | 3 (2.83%) | 118 | |||
| 670 | 168 | M109 | 509 | 386 | 3 (2.83%) | ||
| 541 | 94 | 168 | |||||
| 74 | M112 | 450 | 435 | 5 (4.72%) | |||
| M44/61 | 450 | 212 | 11 (10.38%) | 104 | |||
| 133 | st11014 | 744 | 596 | 5 (4.72%) | |||
| M48 | 710 | 162 | 2 (1.89%) | 620 | 87 | ||
| 592 | 121 | 493 | 29 | ||||
| 471 | 81 |
Figure 3Alignment of amino acid sequences from U768 with M4 (emm4 gene) and P354 with M102 (emm102 gene) in GenBank.
Figure 1Diagrammatic representation of the emm1 and emm25 genes of M1 and M25 proteins, respectively, showing the different A-, B- and C-repeat regions encoding the M protein. The location of the sense and antisense primers used for PCR amplification of the emm gene are indicated as well as the different emm gene amplicons (PCR products) that arise depending upon the number of C-repeat regions within the emm gene.